Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

220
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
220
Global Regulatory Systems01:28

Global Regulatory Systems

60
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
60
Drug Regulation01:25

Drug Regulation

1.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.7K
Competition02:34

Competition

22.1K
When organisms require the same limited resources within an environment, they may have to compete for them. Competition is a net-negative interaction. Even if two competing individuals or populations do not interact directly, the overall fitness of both competitors is lowered as a result of not having full access to the limited resource.
22.1K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk.

Clinical immunology (Orlando, Fla.)·2023
Same author

Correction: Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.

PLoS pathogens·2022
Same author

Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins.

PLoS pathogens·2021
Same author

Recent Developments at DG Competition: 2020/2021.

Review of industrial organization·2021
Same author

Recent Developments at DG Competition: 2019/2020.

Review of industrial organization·2020
Same author

Recent Developments at DG Competition: 2017/2018.

Review of industrial organization·2018
Same journal

Price-Directed Search, Product Differentiation and Competition.

Review of industrial organization·2023
Same journal

Before Privatization There was Its Impact: Sugar Factories in Turkey.

Review of industrial organization·2023
Same journal

Research Diversity and Invention.

Review of industrial organization·2022
Same journal

Patent Licensing and Capacity in a Cournot Model.

Review of industrial organization·2022
Same journal

Economics at the FCC 2021-22: 5G Spectrum Auctions, Affordable Connectivity, Broadband Data Collection, and Merger Review.

Review of industrial organization·2022
Same journal

Recent Developments at the CMA: 2021-22.

Review of industrial organization·2022
See all related articles

Related Experiment Video

Updated: Aug 19, 2025

Author Spotlight: Developing Synthetic Cells from Programmable Amphiphilic DNA Nanostructures
08:02

Author Spotlight: Developing Synthetic Cells from Programmable Amphiphilic DNA Nanostructures

Published on: May 31, 2024

861

Recent Developments at DG Competition: 2021/2022.

Thomas Buettner1, Daniel Coublucq2, Rossitza Kotzeva3

  • 1European Commission, MADO 17/025, 1049 Brussels, Belgium.

Review of Industrial Organization
|December 5, 2022
PubMed
Summary
This summary is machine-generated.

The European Commission

Keywords:
AntitrustCompetition policyMergersState aid

More Related Videos

Density Gradient Multilayered Polymerization DGMP: A Novel Technique for Creating Multi-compartment, Customizable Scaffolds for Tissue Engineering
12:54

Density Gradient Multilayered Polymerization DGMP: A Novel Technique for Creating Multi-compartment, Customizable Scaffolds for Tissue Engineering

Published on: February 12, 2013

12.6K
Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification
07:54

Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification

Published on: March 31, 2021

4.7K

Related Experiment Videos

Last Updated: Aug 19, 2025

Author Spotlight: Developing Synthetic Cells from Programmable Amphiphilic DNA Nanostructures
08:02

Author Spotlight: Developing Synthetic Cells from Programmable Amphiphilic DNA Nanostructures

Published on: May 31, 2024

861
Density Gradient Multilayered Polymerization DGMP: A Novel Technique for Creating Multi-compartment, Customizable Scaffolds for Tissue Engineering
12:54

Density Gradient Multilayered Polymerization DGMP: A Novel Technique for Creating Multi-compartment, Customizable Scaffolds for Tissue Engineering

Published on: February 12, 2013

12.6K
Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification
07:54

Two-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification

Published on: March 31, 2021

4.7K

Area of Science:

  • Competition Law
  • Antitrust
  • Merger Control
  • State Aid

Background:

  • The Directorate General for Competition (DG COMP) enforces EU competition law.
  • The Chief Competition Economist's team plays a key role in economic analysis.
  • Recent developments in 2021/2022 are under review.

Purpose of the Study:

  • To survey key developments at DG COMP in 2021/2022.
  • To highlight significant changes in antitrust, merger control, and State aid.
  • To provide an overview of the economic team's role.

Main Methods:

  • Review of regulatory updates.
  • Analysis of key cases.
  • Presentation of the economic team's function.

Main Results:

  • Introduction of new "Vertical Block Exemption Regulation" and "Vertical Guidelines".
  • Publication of new "Guidelines on State aid for climate, environmental protection, and energy".
  • Review of the significant Veolia/Suez merger case.

Conclusions:

  • DG COMP actively updated its regulatory framework in 2021/2022.
  • New guidelines reflect a focus on climate and environmental objectives in State aid.
  • Merger control remains a key area of enforcement, as exemplified by the Veolia/Suez case.